CytomX Therapeutics to Present at Upcoming November Investor Conferences
Globe Newswire•02/11/2026•08:00 ET
0
Key Highlights
- ➤CytomX management to present at two November investor conferences
- ➤Guggenheim fireside chat scheduled for November 9 in Boston
- ➤Jefferies fireside chat scheduled for November 18 in London
- ➤Clinical pipeline includes Varseta-M and CX-801
- ➤Varseta-M targets metastatic colorectal cancer; CX-801 targets metastatic melanoma
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will participate in the following investor conferences in November.
Guggenheim 3(rd) Annual Healthcare Innovation Conference Date: Monday, November 9, 2026 Fireside Chat: 3:30 p.m. ET Location: Boston, MA
Get started
Create a free account to read the full story.